Publications by authors named "B L Fredensborg"

Parasite-induced modification of host behavior increasing transmission to a next host is a common phenomenon. However, field-based studies are rare, and the role of environmental factors in eliciting host behavioral modification is often not considered. We examined the effects of temperature, relative humidity (RH), time of day, date, and an irradiation proxy on behavioral modification of the ant (Förster, 1850) by the brain-encysting lancet liver fluke (Rudolphi, 1819).

View Article and Find Full Text PDF

The global biodiversity crisis emphasizes our need to understand how different stressors (climatic, chemical, parasitic, etc.) interact and affect biological communities. We provide a comprehensive meta-analysis investigating joint effects of chemical and parasitic stressors for 1064 chemical-parasitic combinations using the Multiplicative model on mortality of arthropods.

View Article and Find Full Text PDF

Background: Currently, no generally accepted curriculum for operating room nurses (OR nurses) working with robotic-assisted surgery (RAS) exists. OR nurses working with RAS require different competencies than regular OR nurses, e.g.

View Article and Find Full Text PDF
Article Synopsis
  • Trichuriasis, caused by the whipworm Trichuris trichiura, is a neglected tropical disease that affects around 500 million people, mainly in areas with poor sanitation where fecal-oral transmission is common.
  • Researchers conducted a population genomics study using whole-genome sequencing of whipworm samples from various locations, including ancient samples dating back up to 1,000 years.
  • The findings indicate a genetic structure among whipworm populations, with the highest genetic variation in Uganda, suggesting an African origin and highlighting potential zoonotic reservoirs, which could help improve genomic epidemiology efforts against this disease.*
View Article and Find Full Text PDF

The probiotic medicinal product TSO (Trichuris suis ova) is administered to patients with active ulcerative colitis in an ongoing clinical phase IIb trial where the typical co-medications are steroids (prednisolone or budesonide) and antibiotics (e.g., phenoxymethylpenicillin).

View Article and Find Full Text PDF